• Aagaard-Tillery KM, Malone FD, Nyberg DA, et al. 2009. Role of second-trimester genetic sonography after down syndrome screening. Obstet Gynecol 114: 11891196.
  • AIUM Practice Guideline for the Performance of Obstetric Ultrasound Examinations. 2007. (ac-cessed 1 December 2010).
  • American College of Obstetrics and Gynecologists. 2007a. ACOG practice bulletin 88. Invasive prenatal testing for aneuploidy. Obstet Gynecol 110: 14591467.
  • American College of Obstetrics and Gynecologists. 2007b. ACOG practice bulletin 77. Screening for fetal chromosomal abnormalities. Obstet Gynecol 109: 217226.
  • Cicero S, Rembouskos G, Vandecruys H, Hogg M, Nicolaides KH. 2004. Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11–14-week scan. Ultrasound Obstet Gynecol 23: 218223.
  • Cuckle H, Benn P. 2010. Multianalyte maternal serum screening for chromosomal defects. In Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment (6th edn), MilunskyA, MilunskyJM (eds) Johns Hopkins University Press: Baltimore.
  • Cuckle H, Aitken D, Goodburn S, Senior B, Spencer K, Standing S. 2004. Age-standardisation for monitoring performance in Down's syndrome screening programmes. Prenat Diagn 24: 851856.
  • Madsen HN, Ball S, Wright D, et al. 2011. A reassessment of biochemical marker distributions in trisomy 21 affected and unaffected twin pregnancies in the first trimester. Ultrasound Obstet Gynecol 37: 3847.
  • Sonek J, Nicolaides K. 2010. Additional first-trimester markers. Clin Lab Med 30: 573592.
  • Spencer K, Staboulidou I, Nicolaides KH. 2010. First trimester aneuploidy screening in the presence of a vanishing twin: implications for maternal serum markers. Prenat Diagn 30: 235240.
  • Tabor A, Alfirevic Z. 2010. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 27: 17.